| Michael J Rupp, MD | |
|
112 N 7th St, Chambersburg, PA 17201-1720 | |
| (717) 267-7973 | |
| (717) 267-7127 |
| Full Name | Michael J Rupp |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 40 Years |
| Location | 112 N 7th St, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275596595 | NPI | - | NPPES |
| 0011688670002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD035540E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Waynesboro Hospital | Waynesboro, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chambersburg Pathology Associates, Inc | 0446296891 | 3 |
| The Gettysburg Hospital | 2769373331 | 46 |
| The Chambersburg Hospital | 5496748303 | 27 |
| Waynesboro Hospital | 6305830936 | 28 |
News Archive
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Rural cancer patients are at an increased risk for financial impact. Compared to their counterparts in cities, cancer patients living in rural areas tend to retire early after being diagnosed, and are less likely to go on paid disability leave while receiving treatment.
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
› Verified 5 days ago
| Entity Name | The Gettysburg Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366472706 PECOS PAC ID: 2769373331 Enrollment ID: O20040323000809 |
News Archive
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Rural cancer patients are at an increased risk for financial impact. Compared to their counterparts in cities, cancer patients living in rural areas tend to retire early after being diagnosed, and are less likely to go on paid disability leave while receiving treatment.
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
› Verified 5 days ago
| Entity Name | Waynesboro Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740287093 PECOS PAC ID: 6305830936 Enrollment ID: O20040414001288 |
News Archive
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Rural cancer patients are at an increased risk for financial impact. Compared to their counterparts in cities, cancer patients living in rural areas tend to retire early after being diagnosed, and are less likely to go on paid disability leave while receiving treatment.
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
› Verified 5 days ago
| Entity Name | Chambersburg Pathology Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437111242 PECOS PAC ID: 0446296891 Enrollment ID: O20050707000339 |
News Archive
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Rural cancer patients are at an increased risk for financial impact. Compared to their counterparts in cities, cancer patients living in rural areas tend to retire early after being diagnosed, and are less likely to go on paid disability leave while receiving treatment.
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
› Verified 5 days ago
| Entity Name | The Chambersburg Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1356669501 PECOS PAC ID: 5496748303 Enrollment ID: O20110808000626 |
News Archive
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Rural cancer patients are at an increased risk for financial impact. Compared to their counterparts in cities, cancer patients living in rural areas tend to retire early after being diagnosed, and are less likely to go on paid disability leave while receiving treatment.
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Rupp, MD 900 Bryan St, Po Box 382, Suite 2, Huntingdon, PA 16652-2413 Ph: (814) 643-6207 | Michael J Rupp, MD 112 N 7th St, Chambersburg, PA 17201-1720 Ph: (717) 267-7973 |
News Archive
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Rural cancer patients are at an increased risk for financial impact. Compared to their counterparts in cities, cancer patients living in rural areas tend to retire early after being diagnosed, and are less likely to go on paid disability leave while receiving treatment.
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
› Verified 5 days ago
Jennifer K. Henaghan, DO Pathology Medicare: Medicare Enrolled Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-267-7973 Fax: 717-267-7127 | |
Lee A Wilkinson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St Dept Of, Chambersburg, PA 17201 Phone: 717-267-7973 Fax: 717-267-7127 | |
Dr. Margaret M. Flanagan, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 814-643-6207 Fax: 814-643-6165 |